Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A study of clinico‐pathological parameters and O6 – methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma

1 Mar 2012

Abstract excerpt

Gliosarcoma is a rare variant of glioblastoma multiforme (GBM) with similar clinical presentation and prognosis but a distinct genetic profile. The clinicopathological features of 22 cases of gliosarcoma were analyzed with respect to age, sex, KPS score, operative diagnosis, extent of resection and histopathological subtype (predominantly sarcomatous [PS], predominantly gliomatous [PG] or mixed). Twelve cases...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Metastases and Treatment
Share to Glioma Diagnosis and Treatment
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22380407
DOI: 10.1111/j.1440-1789.2012.01297.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A study of clinico‐pathological parameters and O6 – methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcomaPMID 22380407Read ↗

Clinicopathologic and genomic features of gliosarcomas.Semantic proximity Read ↗

Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.Semantic proximity Read ↗

Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review.Semantic proximity Read ↗

Primary versus secondary gliosarcoma: a systematic review and meta-analysis.Semantic proximity Read ↗

Prognostic factors of gliosarcoma in the real world: a retrospective cohort studySemantic proximity Read ↗

MGMT Promoter Methylation: Prognostication beyond Treatment ResponseSemantic proximity Read ↗

Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre studySemantic proximity Read ↗

Gliosarcoma with Osteosarcomatous Component: A Case Report and Short Review IllustrationSemantic proximity Read ↗

O 6 -methylguanine DNA methyltransferase gene promoter methylation in high-grade gliomas: A review of current statusSemantic proximity Read ↗

The Impact of MGMT Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary GlioblastomaSemantic proximity Read ↗

Genetic profile of gliosarcomas.Semantic proximity Read ↗

MGMT Gene Silencing and Benefit from Temozolomide in GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.